RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 100-110
  • SEC reviewing attempted takeover of Botox maker Allergan

    The Securities and Exchange Commission is looking into the way that a Canadian pharmaceutical company and activist investor Bill Ackman have tried to buy Botox maker Allergan Inc. of Irvine. Ackman's hedge fund, Pershing Square Capital Management,...
  • SEC is investigating bid by Valeant and Bill Ackman for Allergan

    The Securities and Exchange Commission is looking into the way a Canadian pharmaceutical company and activist investor Bill Ackman have tried to buy Botox maker Allergan Inc. of Irvine. Word of the investigation came less than a week after Allergan sued...
  • An O.C. couple do the math: Same drug is far cheaper in Canada

    An O.C. couple do the math: Same drug is far cheaper in Canada
    Bent and Henni Christensen consider themselves patriotic Americans and strong supporters of Medicare. Nevertheless, the Huntington Beach couple buy most of their prescription drugs from an online Canadian pharmacy at prices much lower than in the United...
  • Tips for keeping medication costs down

    Tips for keeping medication costs down
    Amanda Greene relies on lidocaine patches to help manage the chronic pain that her Lupus causes. The anesthetic is available as a generic drug, typically sold at a substantially lower price. But this year, the 47-year-old Culver City resident says she's...
  • MannKind agrees to license its inhaled-insulin drug Afrezza to Sanofi

    MannKind agrees to license its inhaled-insulin drug Afrezza to Sanofi
    Less than two months after receiving approval for an inhalable form of insulin, MannKind Corp. agreed to license the drug to Paris-based Sanofi in a deal that could provide the Valencia company with $925 million. Sanofi will initially pay MannKind $150...
  • Close loopholes that let U.S. firms avoid taxes by using inversions

    Close loopholes that let U.S. firms avoid taxes by using inversions
    It's both endearing and infuriating to watch American corporate executives wring their hands about how the injustices of the U.S. tax code are forcing them — forcing them! — to reincorporate overseas through the procedure known as inversion....
  • American Ebola patients become serum test subjects

    American Ebola patients become serum test subjects
    There is no vaccine or proven treatment for patients stricken with Ebola, but two ailing Americans who were infected with the deadly virus while working in the West African nation of Liberia have become test subjects for an experimental serum that they...
  • Use of experimental Ebola drug raises red flags among medical experts

    Two American aid workers were gravely ill, fighting to survive infection with the deadly Ebola virus. A San Diego drug company had three doses of an experimental Ebola medicine that showed promise in monkeys but had never been tested in humans....
  • Poultry firms systematically feed low-dose antibiotics to flocks

    Poultry firms systematically feed low-dose antibiotics to flocks
    Major U.S. poultry firms are administering antibiotics to their flocks far more pervasively than regulators realize, posing a potential risk to human health. Internal records examined by Reuters reveal that some of the nation's largest poultry producers...
  • AbbVie sued by FTC for paying to delay generic drug

    AbbVie sued by FTC for paying to delay generic drug
    The Federal Trade Commission has filed suit against North Chicago-based AbbVie and a partner, alleging the companies illegally blocked consumer access to generic versions of the testosterone replacement drug AndroGel in order to reap hundreds of...
  • Pill look different? Shape and color changes may prompt lapses

    Pill look different? Shape and color changes may prompt lapses
    In a decade, Americans have saved an estimated $1.2 trillion by taking generic drugs instead of the high-priced originals. But the booming market in copycat prescription pharmaceuticals - coupled with insurance companies' efforts to keep healthcare...